Mepacrine, a phospholipase inhibitor. A potential tool for modifying myocardial reperfusion injury.

[1]  M. Jain,et al.  Action of phospholipase A2 on bilayers containing lysophosphatidylcholine analogs and the effect of inhibitors. , 1984, Biochemical pharmacology.

[2]  S. Lemeshow,et al.  Performance of pig heart after 30 or 120 minutes hypothermic arrest. , 1983, The Journal of surgical research.

[3]  A. Tauber,et al.  Dissociation of human neutrophil membrane depolarization, respiratory burst stimulation and phospholipid metabolism by quinacrine , 1983, FEBS letters.

[4]  M. Post,et al.  Mechanisms involved in the synthesis of disaturated phosphatidylcholine by alveolar type II cells isolated from adult rat lung. , 1983, Biochimica et biophysica acta.

[5]  E. Bohn,et al.  Effects of antimalarial drugs on several rat-liver lysosomal enzymes involved in phosphatidylethanolamine catabolism. , 1982, Biochimica et biophysica acta.

[6]  P. Grinwald,et al.  Calcium entry in the calcium paradox. , 1981, Journal of molecular and cellular cardiology.

[7]  N. Shaikh Time Course of Changes in Porcine Myocardial Phospholipid Levels during Ischemia: A Reassessment of the Lysolipid Hypothesis , 1981, Circulation research.

[8]  K. Chien,et al.  Phospholipid Alterations in Canine Ischemic Myocardium: Temporal and Topographical Correlations with Tc‐99m‐PPi Accumulation and an in Vitro Sarcolemmal Ca2+ Permeability Defect , 1981, Circulation research.

[9]  R. Narbaitz,et al.  Membrane changes induced by early myocardial ischemia in the dog. , 1980, Canadian journal of biochemistry.

[10]  H. Kammermeier,et al.  Rapid assay of adenine nucleotides or creatine compounds in extracts of cardiac tissue by paired-ion reverse-phase high-performance liquid chromatography. , 1980, Analytical biochemistry.

[11]  J. Farber,et al.  Ischemic myocardial cell injury. Prevention by chlorpromazine of an accelerated phospholipid degradation and associated membrane dysfunction. , 1979, The American journal of pathology.

[12]  R. Engelman,et al.  The time course of myocardial high-energy phosphate degradation during potassium cardioplegic arrest. , 1979, Surgery.

[13]  J. Farber,et al.  Accelerated phospholipid degradation and associated membrane dysfunction in irreversible, ischemic liver cell injury. , 1978, The Journal of biological chemistry.

[14]  R. Engelman,et al.  The significance of multidose cardioplegia and hypothermia in myocardial preservation during ischemic arrest. , 1978, The Journal of thoracic and cardiovascular surgery.

[15]  J. Farber,et al.  Prevention by chlorpromazine of ischemic liver cell death. , 1977, The American journal of pathology.

[16]  J. Farber,et al.  Microsomal membrane dysfunction in ischemic rat liver cells. , 1977, Archives of biochemistry and biophysics.

[17]  D. E. Goll,et al.  A Ca2+-activated protease possibly involved in myofibrillar protein turnover. Partial characterization of the purified enzyme. , 1976, Biochemistry.

[18]  R. Engelman,et al.  The effect of normothermic anoxic arrest and ventricular fibrillation on the coronary blood flow distribution of the pig. , 1975, The Journal of thoracic and cardiovascular surgery.

[19]  R. Jennings,et al.  Myocardial calcium and magnesium in acute ischemic injury. , 1972, The American journal of pathology.

[20]  R. Jennings,et al.  Kinetics of calcium accumulation in acute myocardial ischemic injury. , 1972, The American journal of pathology.

[21]  S. Shohet,et al.  Myocardial phospholipase A of microsomal and mitochondrial fractions. , 1971, Biochimica et biophysica acta.

[22]  G. R. Bartlett Phosphorus assay in column chromatography. , 1959, The Journal of biological chemistry.

[23]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[24]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[25]  B. Brodie,et al.  THE ESTIMATION OF ATABRINE IN BIOLOGICAL FLUIDS AND TISSUES , 1943 .